Cargando…

Interleukin-15 in Outcomes of Pregnancy

Interleukin-15 (IL-15) is a pleiotropic cytokine that classically acts to support the development, maintenance, and function of killer lymphocytes. IL-15 is abundant in the uterus prior to and during pregnancy, but it is subject to tight spatial and temporal regulation. Both mouse models and human s...

Descripción completa

Detalles Bibliográficos
Autor principal: Gordon, Scott M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541205/
https://www.ncbi.nlm.nih.gov/pubmed/34681751
http://dx.doi.org/10.3390/ijms222011094
_version_ 1784589173326348288
author Gordon, Scott M.
author_facet Gordon, Scott M.
author_sort Gordon, Scott M.
collection PubMed
description Interleukin-15 (IL-15) is a pleiotropic cytokine that classically acts to support the development, maintenance, and function of killer lymphocytes. IL-15 is abundant in the uterus prior to and during pregnancy, but it is subject to tight spatial and temporal regulation. Both mouse models and human studies suggest that homeostasis of IL-15 is essential for healthy pregnancy. Dysregulation of IL-15 is associated with adverse outcomes of pregnancy. Herein, we review producers of IL-15 and responders to IL-15, including non-traditional responders in the maternal uterus and fetal placenta. We also review regulation of IL-15 at the maternal–fetal interface and propose mechanisms of action of IL-15 to facilitate additional study of this critical cytokine in the context of pregnancy.
format Online
Article
Text
id pubmed-8541205
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85412052021-10-24 Interleukin-15 in Outcomes of Pregnancy Gordon, Scott M. Int J Mol Sci Review Interleukin-15 (IL-15) is a pleiotropic cytokine that classically acts to support the development, maintenance, and function of killer lymphocytes. IL-15 is abundant in the uterus prior to and during pregnancy, but it is subject to tight spatial and temporal regulation. Both mouse models and human studies suggest that homeostasis of IL-15 is essential for healthy pregnancy. Dysregulation of IL-15 is associated with adverse outcomes of pregnancy. Herein, we review producers of IL-15 and responders to IL-15, including non-traditional responders in the maternal uterus and fetal placenta. We also review regulation of IL-15 at the maternal–fetal interface and propose mechanisms of action of IL-15 to facilitate additional study of this critical cytokine in the context of pregnancy. MDPI 2021-10-14 /pmc/articles/PMC8541205/ /pubmed/34681751 http://dx.doi.org/10.3390/ijms222011094 Text en © 2021 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gordon, Scott M.
Interleukin-15 in Outcomes of Pregnancy
title Interleukin-15 in Outcomes of Pregnancy
title_full Interleukin-15 in Outcomes of Pregnancy
title_fullStr Interleukin-15 in Outcomes of Pregnancy
title_full_unstemmed Interleukin-15 in Outcomes of Pregnancy
title_short Interleukin-15 in Outcomes of Pregnancy
title_sort interleukin-15 in outcomes of pregnancy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541205/
https://www.ncbi.nlm.nih.gov/pubmed/34681751
http://dx.doi.org/10.3390/ijms222011094
work_keys_str_mv AT gordonscottm interleukin15inoutcomesofpregnancy